Equibles does not estimate personal net worth.
Get an email with a short summary when Baxter International Inc publishes a filing, an earnings call transcript or a press release.
Get BAX alertsHeather Knight is recorded as COO at Baxter International Inc (BAX) since February 3, 2025. The newest filing on record that lists Heather Knight as COO at Baxter International Inc (BAX) is dated March 23, 2026. Baxter International Inc reported in an 8-K filed October 21, 2025 that Heather Knight resigned as interim group president of Medical Products and Therapies ("MPT"), effective October 29, 2025. Baxter International Inc reported in an 8-K filed October 21, 2025 that Heather Knight resigned as Executive Vice President, Chief Operating Officer, effective October 29, 2025. Baxter International Inc reported in an 8-K filed February 3, 2025 that Heather Knight was appointed Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies, effective February 3, 2025. Equibles holds 4 filed executive changes naming Heather Knight; each is listed under recent activity with its source filing. The proxy statement of Baxter International Inc reports total compensation of $6,074,548 for Heather Knight in fiscal 2025, including a base salary of $747,123. Disclosed compensation is on record for 3 fiscal years. Heather Knight has spoken on 3 earnings calls across 1 company, most recently for Baxter International Inc on July 31, 2025. Baxter International Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Baxter International Inc includes Andrew Hider (CEO, CFO and Board Member), Brent Shafer (CEO and Chairman), José Almeida (CEO) and 7 others.
“On October 16, 2025, Heather Knight notified Baxter International Inc. (the "Company") of her decision to resign as the Company's Executive Vice President, Chief Operating Officer ("COO") and interim group president of Medical Products and Therapies ("MPT"), effective as of October 29, 2025 (the "Transition Date"), to join a company in the healthcare industry.”
“On October 16, 2025, Heather Knight notified Baxter International Inc. (the "Company") of her decision to resign as the Company's Executive Vice President, Chief Operating Officer ("COO") and interim group president of Medical Products and Therapies ("MPT"), effective as of October 29, 2025 (the "Transition Date"), to join a company in the healthcare industry.”
“Good morning. and thanks for the question so there was no impact in the second quarter from Novum as I said in the prepared remarks we just made this decision voluntarily a couple weeks ago and just want to reinforce that we remain confident in the Novum platform there are significant advantages with this pump over…”
“I'm pleased to be here with you this morning to discuss our first quarter results. I'm going to walk through our sales performance in the quarter, and then we'll hand it over to Joel to walk through performance across the rest of the P&L, along with our financial outlooks for the second quarter and full year 2025.”
“I'm very pleased to be joining today's call. I look forward to building upon what we've achieved to date and helping to launch a new chapter of accelerated performance for the company.”
2025-02-03–present
Last confirmed March 23, 2026
SEC 8-K
2023-03-01–present
Start not stated–2025-10-29
Proxy statement
Start not stated–2025-10-29
Medical Instruments & Supplies · Healthcare
COO
2023-03-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Baxter International Inc (BAX) | Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies | $747,123 | $6,074,548 |
| 2024 | Baxter International Inc (BAX) | Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies | $883,333 | $6,596,490 |
| 2023 | Baxter International Inc (BAX) | Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies | $791,507 | $4,860,243 |
